Randomized controlled study of extracorporeal albumin dialysis for hepatic encephalopathy in advanced cirrhosis

2007402 citationsJournal Articlebronze Open Access

Authors

Tarek Hassanein · University of California, San Diego

Flemming Tofteng · Rigshospitalet

Robert S. Brown · Columbia University

Brendan M. McGuire · University of Alabama

Patrick Lynch

Ravindra L. Mehta · University of California, San Diego

Fin Stolze Larsen · Rigshospitalet

Abstract

The use of ECAD may be associated with an earlier and more frequent improvement of HE (grade 3/4). Because this 5-day study was not designed to examine the impact of MARS on survival, a full assessment of the role of albumin dialysis awaits the results of additional controlled trials.

Topics & Keywords

Liver Disease and Transplantation Liver Disease Diagnosis and Treatment Organ Transplantation Techniques and Outcomes

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Hepatology

Volume 46, Issue 6, pp. 1853-1862

DOI: 10.1002/hep.21930

Field-Weighted Citation Impact: 12.52